"Maximum out-of-pocket limit." 2025 Medicare Advantage MOOP: $9,350 in-network
Increased Thyroid Cancer Risk Not Observed After Use of GLP1 Receptor Agonist Ariana Pelosci Patients who are predisposed to medullary thyroid cancer should be advised against the use of GLP1 agents
On one hand, it can degrade intestinal mucin glycoproteins by enzymes (such as glycoside hydrolases, proteases, sulfatases, and sialidases) to produce SCFAs, acetates, propionates, and 1,2-propanediol, as well as succinates and sulfates, promoting mucin turnover and thickening, thereby enhancing intestinal barrier function and reducing the permeability of gut microbiota products
This persistent challenge likely reflects multiple factors including prior metabolic adaptations, changes in body composition, lifestyle factors, and possibly residual metabolic effects not fully corrected by thyroid hormone replacement alone